ArticleParkinson's disease2025

The Cost-Effectiveness of Opicapone Versus Entacapone as Adjuvant Therapy for Levodopa-Treated Individuals With Parkinson's Disease Experiencing End-of-Dose Motor Fluctuations.

Glynn Harrison-Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.